Sort
51,593 grants matching “hepatitis”
Mechanisms linking insulin action with lipoprotein metabolism
$539,237Rebecca Anne Haeusler · Columbia University Health Sciences · R01 · FY2022 · HL
Mechanisms linking insulin action with lipoprotein metabolism
$539,236Rebecca Anne Haeusler · Columbia University Health Sciences · R01 · FY2020 · HL
Mechanisms linking insulin action with lipoprotein metabolism
$539,236Rebecca Anne Haeusler · Columbia University Health Sciences · R01 · FY2021 · HL
Mechanisms linking insulin action with lipoprotein metabolism
$539,236Rebecca Anne Haeusler · Columbia University Health Sciences · R01 · FY2023 · HL
Coactivator P300 promotes hepatic steatosis in obesity
$539,185Ling He · Johns Hopkins University · R01 · FY2021 · DK
Quality of life outcomes in prescription and injection opioid dependence
$539,174Bruce R Schackman · Weill Medical Coll Of Cornell Univ · R01 · FY2012 · DA
A systematic analysis of small RNA interactions during RNA virus infections
$539,134Charles M. Rice · Rockefeller University · R01 · FY2016 · AI
Phospholipid-Mediated Metabolic Control in Liver and Brown Adipose Tissue
$539,020David E Cohen · Brigham And Women'S Hospital · R01 · FY2011 · DK
MAF1 Function and Metabolic Inefficiency
$539,012Ian M Willis · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · GM
CORE--BIOINFORMATICS
$539,010Robert C Young · Fox Chase Cancer Center · P30 · FY2009 · CA
The Lipin Protein Family and Triglyceride Metabolism
$539,000Karen Reue · University Of California Los Angeles · P01 · FY2014 · HL
Targeting matrix stiffness in lung and liver fibrosis
$538,996Daniel J. Tschumperlin · Mayo Clinic Rochester · R01 · FY2018 · HL
Targeting matrix stiffness in lung and liver fibrosis
$538,996Daniel J. Tschumperlin · Mayo Clinic Rochester · R01 · FY2017 · HL
Mitochondrial depolarization, mitophagy, and mitochondrial DAMPs in ALD
$538,978Zhi Zhong · Medical University Of South Carolina · R01 · FY2023 · AA
Mitochondrial depolarization, mitophagy, and mitochondrial DAMPs in ALD
$538,978Zhi Zhong · Medical University Of South Carolina · R01 · FY2024 · AA
Mitochondrial depolarization, mitophagy, and mitochondrial DAMPs in ALD
$538,978Zhi Zhong · Medical University Of South Carolina · R01 · FY2025 · AA
Axin Stabilization by Novel Small Molecules to Treat Non-alcoholic Steatohepatitis
$538,952Yan Shu · University Of Maryland Baltimore · R01 · FY2023 · DK
Obesity, chemotherapy dosing, and breast cancer outcomes
$538,940Elizabeth David Kantor · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA
DNA Adduct-Induced Mutagenesis
$538,804Michael P Stone · Vanderbilt University · R01 · FY2018 · ES
Alpha and Beta Cell Function in Normal and Diabetic Man
$538,710University Of Rochester · R01 · FY2005 · DK
M2 peptide based vaccines against influenza
$538,677Andrew S. Pekosz · Johns Hopkins University · U01 · FY2008 · AI
Role of Screening and Early Intervention in Primary Care with Low-Dose Pioglitazone for Patients with T2DM and NASH
$538,644Kenneth Cusi · University Of Florida · R01 · FY2023 · DK
Novel Pathways of Cellular Cholesterol Efflux
$538,613Alan Richard Tall · Columbia University Health Sciences · P01 · FY2007 · HL
GENE THERAPY FOR HEMOPHILIA A AND B
$538,537Salk Institute For Biological Studies · R01 · FY2000 · HL
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates
$538,512Gerald I Shulman · Yale University · R01 · FY2020 · DK